estimate relatively

See: compare
References in periodicals archive ?
Despite potential advances in stroke trial design, we believe that only clomethiazole will gain market approval during our 1998-2008 forecast period, and we estimate relatively modest seven-market peak-year sales of $150-$250 million because we believe the drug will benefit only specific patient subgroups.